Tapentadol is partly metabolized from the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medicine that enhance or repress the action/expression of a number of of such enzymes, and also with substrates of such enzymes (as a consequence of Competitors for the enzyme); some enzyme mediators/substrates call for dosing … Read More